Inside Drug Pricing - 01/13/2020

Circuit Court Takes Up Drug Ad Rule; Maryland Drug Board Holds First Meeting; MedPAC Discusses Part D Redesign, 340B Incentives

By John Wilkerson, Ariel Cohen / January 13, 2020 at 12:36 PM
On Monday (Jan. 13), a D.C. Circuit Court will hear arguments on HHS’ rule to require that television drug ads disclose list prices, and the Maryland Prescription Drug Affordability Board will hold its first meeting. Later this week, congressional Medicare advisers will discuss new designs for Medicare Part D and go over a report on whether the 340B drug discount program encourages hospitals to choose expensive drugs over cheaper alternatives. In October 2018, HHS proposed forcing drug makers to disclose...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.